Human CD46 (membrane cofactor protein), which serves as a receptor for a variety of pathogens, including strains of measles virus, human herpesvirus type 6 and Neisseria, is rapidly downregulated from the cell surface following infection by these pathogens. Here, we report that replicationincompetent adenovirus (Ad) serotype 35 (Ad35) vectors, which belong to subgroup B and recognize human CD46 as a receptor, downregulate CD46 following infection. A decline in the surface expression of CD46 in human peripheral blood mononuclear cells was detectable 6 h after infection, and reached maximum (72%) 12 h after infection. Ad35 vectorinduced downregulation of surface CD46 levels gradually recovered after the removal of Ad35 vectors, however, complete recovery of CD46 expression was not observed even at 96 h after removal. The surface expression of CD46 was also reduced after incubation with fiber-substituted Ad serotype 5 (Ad5) vectors bearing Ad35 fiber proteins, ultraviolet-irradiated Ad35, vectors and recombinant Ad35 fiber knob proteins; in contrast, conventional Ad5 vectors did not induce surface CD46 downregulation, suggesting that the fiber knob protein of Ad35 plays a crucial role in the downregulation of surface CD46 density. These results have important implications for gene therapy using CD46-utilizing Ad vectors and for the pathogenesis of Ads that interact with CD46. Gene Therapy (2007) 14, 912-919.
Introduction
Human CD46 is a transmembrane glycoprotein, which is ubiquitously expressed in most or all human nucleated cells. CD46 functions as a regulator of complement activation, whose normal function is to protect the host from autologous complement attack, by binding complement components C3b and C4b and facilitating their cleavage by factor I. 1, 2 In addition to these functions, CD46 serves as a receptor for several pathogens, including strains of measles virus (MV), 3 human herpesvirus type 6 (HHV6), 4 group A streptococci 5 and Neisseria. 6 Among these pathogens, infection by certain strains of MV, 7, 8 HHV6 4 and Neisseria gonorrhoeae 9 has been shown to cause CD46 downregulation from the cell surface. The detailed mechanisms of surface CD46 downregulation upon infection by these pathogens remain to be elucidated, however, the decrease in the surface density of CD46 renders the cells more susceptible to lysis by complements, as demonstrated in vitro, 10 and may contribute to the attenuation of these pathogens by rapid clearing of infected cells.
Recently, it has been demonstrated that CD46 also acts as a receptor for the majority of subgroup B adenoviruses (Ads), including Ad serotypes 11 (Ad11) and 35 (Ad35). 11, 12 The fiber knob domain of Ad11 or Ad35 binds to short consensus repeats (SCRs) 1 and/or 2 in CD46 for infection. [13] [14] [15] Furthermore, Ad35 competes for binding to CD46 with the MV hemagglutinin (MVH) protein, 14 which is responsible for both the attachment of MV to CD46 16 and downregulation of surface CD46 expression levels. 17 These findings led us to hypothesize that CD46 is downregulated following infection by subgroup B Ads, as occurs in the case of MV. On the other hand, subgroup B Ad11 and Ad35 are considered to be an attractive framework for gene transfer vectors for the following reasons. First, Ad11 and Ad35 are known to be rarely neutralized by human sera. 18 Second, Ad11 and Ad35 exhibit a broad tropism including cells expressing no or low levels of coxsackievirus and adenovirus receptor (CAR), which is a receptor for Ads belonging to subgroups A, C, D, E and F. 19 Several groups (including the authors) have developed replication-incompetent Ad vectors composed of subgroup B Ads [20] [21] [22] [23] [24] or fibersubstituted Ad serotype 5 (Ad5) vectors containing subgroup B Ad fibers, [25] [26] [27] [28] and have demonstrated that these types of Ad vectors efficiently transduce a variety of human cells, including cells refractory to conventional Ad5 vectors. If surface CD46 downregulation occurs following transduction with CD46-utilizing Ad vectors, unexpected side effects might occur such as complementmediated cell lysis of successfully transduced cells, which leads to clearance of the transduced cells.
In the present study, we examined replication-incompetent Ad35 vector-induced downregulation of surface CD46 expression. We found that transduction with Ad35 vectors significantly downregulated CD46 expression from the cell surface in a dose-dependent and cell typespecific manner. Ad35 vector-mediated downregulation of surface CD46 was found to occur in leukemia cells, whereas nonleukemia cells did not exhibit any decline in surface CD46 expression following Ad35 vector infection. To the best of our knowledge, this is the first report characterizing subgroup B Ad-mediated downregulation of surface CD46.
Results

Infection with Ad35 vectors causes downregulation of surface CD46 expression
To determine whether infection with Ad35 vectors results in modulation of surface CD46 expression, human peripheral blood mononuclear cells (PBMCs) were incubated with the Ad35 vector expressing green fluorescence protein (GFP) (Ad35GFP) at 10 000 vector particle (VP)/cell and subjected to flow cytometric analysis at various time points. This analysis demonstrated that the surface expression levels of CD46 in PBMCs gradually decreased during exposure to Ad35GFP (Figure 1a) . The significant decrease in CD46 was detectable 6 h after infection and reached maximum 12 h after infection (72% downregulation). Furthermore, the downregulation of surface CD46 by Ad35 vectors was found to be dose dependent (Figure 1b) . PBMCs infected at 1250 VP/cell showed significantly reduced levels of CD46 expression (44% downregulation), and 71% downregulation of surface CD46 expression was induced at 20 000 VP/cell. These results indicate that infection with Ad35 vectors downregulates surface CD46 expression, as happens in the cases of MV 7, 8 and HHV6. 4 The viability of PBMCs was not significantly affected by Ad35 vector infection (data not shown).
Next, in order to examine whether B cells (CD19 + cells) and T cells (CD3 + cells) in PBMCs show a reduction in surface CD46 levels after infection with Ad35 vectors, PBMCs were simultaneously stained with anti-human CD46 and anti-human CD19 or anti-human CD3 antibodies, and were subsequently subjected to flow cytometric analysis. Surface CD46 downregulation was found in both B cells and T cells after Ad35 vector infection, but the levels of the downregulation in these cells were lower than those of whole PBMCs (Figure 1c) . Surface CD46 expression in T cells was more largely reduced than that in B cells. We also investigated seven additional human cells (Molt-4, KG-1a, K562, U937, A549, HeLa and human bone marrow-derived CD34 + cells) for Ad35 vector-induced downregulation of surface CD46 levels; the downregulation levels of surface CD46 were different among the cell types (Table 1) 
Total protein levels and mRNA levels of CD46 are not reduced following Ad35 vector infection
To examine the mechanism of Ad35 vector-induced downregulation of surface CD46, Western blotting and semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for CD46 expression were performed. Western blotting analysis using total cellular lysates demonstrated that the total cellular levels of CD46 were not reduced, but rather seemed to slightly increase, during 48 h of exposure to Ad35GFP ( Figure  2a ), suggesting that CD46 may be internalized after infection by Ad35 vectors without intracellular degradation, as in the case of MV. 7 In addition, infection by Ad35GFP did not decrease the mRNA levels of CD46 ( Figure 2b ). These results indicate that infection by Ad35 vectors does not downregulate the transcription of the CD46 gene.
Fiber knob proteins of subgroup B Ads play a crucial role in the decrease in surface CD46 expression
To investigate which parts of Ad35 are involved in the downregulation of surface CD46 levels, PBMCs were incubated with conventional Ad5 vectors, fiber-substituted Ad5 vectors displaying the Ad35 fiber shaft and knob, and ultraviolet (UV)-or heat-inactivated Ad35 vectors at 10 000 VP/cell for 24 h. The conventional Ad5 vectors expressing GFP, Ad5GFP, which utilizes CAR for infection, did not downregulate CD46, whereas infection by the Ad5F35 vector expressing GFP, Ad5F35GFP, which recognizes CD46 for infection, significantly reduced surface CD46 expression by 72% (Figure 3a) . UVinactivated Ad35GFP also induced the downregulation of surface CD46 by 62% following infection, which was a level similar to that of surface CD46 downregulation induced by Ad35GFP. However, heat-inactivated Ad35GFP produced a lower level of surface CD46 downregulation than UV-inactivated Ad35GFP. This low level of CD46 downregulation by heat-inactivated Ad35GFP would be due to the thermal denaturation of fiber proteins in Ad35GFP. Next, PBMCs were incubated with recombinant Ad5 or Ad35 fiber knob proteins to further examine the role of Ad35 fiber protein in the downregulation of surface CD46 expression. Ad35 fiber knob proteins were found to downregulate the surface expression levels of CD46 in a dose-dependent manner, and maximal downregulation of surface CD46 was induced by 55% at 4 mg/ml ( Figure  3b ). In contrast, no significant reduction in surface CD46 levels was found after incubation with Ad5 fiber knob proteins. These results indicate that fiber knob proteins of Ad35 play a crucial role in the downregulation of surface levels of CD46.
Downregulated CD46 expression is not rapidly restored after the removal of Ad35 vectors
Next, we examined how long it takes to restore surface CD46 expression after Ad35 vector-induced downregulation. Downregulation of surface CD46 induced by Ad35GFP gradually recovered after resuspension, however, the recovery kinetics of CD46 expression after the removal of Ad35 vectors was much lower than the kinetics of Ad35 vector-induced decrease in the surface CD46 (Figure 4 ). CD46 expression was downregulated by 65% before resuspension, and surface CD46 expression remained reduced by 53 and 49% at 24 and 48 h after resuspension, respectively. Complete restoration of surface CD46 expression was not observed even at 96 h after resuspension, at which point 17% downregulation remained, thus, more than 96 h are required to restore completely surface CD46 expression after Ad35 vectorinduced downregulation.
Discussion
Understanding the interaction between cellular receptors and viruses and subsequent events following the attachment of viruses to receptors is important to elucidate the 
MV-induced downregulation of surface CD46 has been the most thoroughly studied aspect of the effects of pathogens recognizing CD46. Nevertheless, the precise mechanisms of MV-induced downregulation of surface CD46 remain to be clarified; surface CD46 downregulation by MV exhibits similar properties to that induced by Ad35 vectors. First, surface expression levels of CD46 are reduced, whereas the total cellular protein levels of CD46 are not significantly decreased after infection, 7 as demonstrated by Western blotting analysis (Figure 2a) . These results suggest that CD46 may be internalized without degradation following infection by MV or Ad35. Second, the protein components, which bind to CD46 in the virion, MVH proteins and fiber knob proteins of Ad35, are involved with surface CD46 downregulation. Previous studies indicate that direct protein-protein contact between CD46 and MVH proteins is necessary for the MV-induced downregulation of surface CD46 levels. 31, 32 The present data in Figure 3 indicate that fiber knob proteins of Ad35 play a crucial role in the reduction in surface CD46 expression. These common properties suggest that Ad35 might downregulate the surface expression levels of CD46 through a mechanism similar to the one that acts in the case of MV. This hypothesis is further supported by previous findings that both the MVH and fiber knob proteins of Ad35 recognize the domains within SCR1 and 2 of CD46. [13] [14] [15] 33, 34 However, the Ad35 vector-mediated modulation of CD46 expression in nonleukemia cells differed from that induced by MVH protein: Ad35 vectors did not produce any decline in CD46 expression in the nonleukemia cells used in the present study (HeLa, A549 and human bone marrow-derived CD34 + cells). We have also demonstrated that surface CD46 expression was not decreased following Ad35 vector infection in Chinese hamster ovary (CHO) transformants expressing CD46 15 (data not shown), however, the MVH protein downregulated CD46 expression in HeLa cells 31 and in CHO transformants stably expressing CD46. 35 These findings suggest that cellular events following the binding of Ad35 vectors to CD46 would be somewhat different from those induced by MV in nonleukemia cells. Downregulation of surface CD46 levels by Ad35 vectors seems inefficient compared with that induced by MV. An approximately 24% reduction in CD46 expression was achieved in U937 cells 24 h following infection of Ad35L at 10 000 VP/cell, which is an approximate multiplicity of infection (MOI) of 50. In contrast, infection by MV strain Edmonston in U937 cells Downregulation of human CD46 by Ad35 F Sakurai et al induced a decline of about 70% in CD46 expression 12 h after infection even at an MOI of 5. 31 The lower levels of surface CD46 downregulation caused by replicationincompetent Ad35 vectors might be partly due to a lack of virus replication; a previous study suggests that newly synthesized MVH proteins in the infected cells further downregulate surface CD46 expression. 31 Piliated N. gonorrhoeae, which also utilizes CD46 as a receptor, exhibits surface CD46 downregulation by the shedding of CD46. 9 The total levels of CD46 in the whole-cell lysates are reduced, and soluble CD46 is found in cell culture supernatants after exposure to piliated N. gonorrhoeae. It now remains unclear how piliated N. gonorrhoeae induces shedding of CD46. However, it is unlikely that Ad35 vector-induced shedding of CD46 occurs because total cellular levels of CD46 were not reduced following infection with Ad35 vectors (Figure 2a) .
It is surprising that the downregulation of surface CD46 expression was not readily restored after the removal of Ad35 vectors because pulse-chase analysis of CD46 showed that matured forms of CD46 are synthesized within 1 h. 36 This raises the question of why newly synthesized CD46 is not transported to the surface membrane in Ad35 vector-infected cells and where newly synthesized CD46 stays in the cells. Further studies are necessary to address these questions.
Previous studies have demonstrated the increased susceptibility of cells to complement-mediated lysis as a result of surface CD46 downregulation, 10,31 however, we found no apparent lysis of PBMCs in vitro by complements following Ad35 vector infection (data not shown). It is now unclear why the complement-mediated cell lysis did not occur in cells showing CD46 downregulation by Ad35 vectors. One possible explanation is that the decreased levels of surface CD46 by Ad35 vectors might be enough to block the complement-mediated cell lysis. Other complement regulatory proteins might compensate the reduction in surface CD46 levels. Although PBMCs showing the reduction in surface CD46 density did not exhibit an apparent increase in susceptibility to complement-mediated cell lysis in vitro, this study suggests that we should exercise caution in the use of CD46-utilizing Ad vectors. The reduction in CD46 expression in cells transduced with CD46-utilizing Ad vectors might cause unexpected side effects after in vivo application. Recently, CD46 has been demonstrated to be involved in not only complement regulation but also various cellular functions, such as immune responses. 37, 38 It is essential to further examine the influence of surface CD46 downregulation, including the fate of the transduced cells, before initiating clinical applications of CD46-utilizing Ad vectors. Additionally, the influence of surface CD46 downregulation in vivo should be evaluated in nonhuman primates; the use of human CD46-transgenic mice is not recommended because rodent CD46 expression is limited in testis, and other complement regulators, such as decay-accelerating factor, protect cells from complement attack in rodents. 39 In summary, we have shown that infection by Ad35 vectors induces downregulation of human CD46 from the cell surface in a dose-dependent and cell typespecific manner. In addition to Ad35 vectors, fibersubstituted Ad5 vectors containing fiber proteins derived from Ad35 also downregulate the surface expression of CD46. Once the surface expression levels of CD46 have declined, CD46 expression is not readily restored after the removal of Ad35 vectors. The present study provides important clues for clarifying the pathogenicity of subgroup B Ad, and suggests caution in the use of Ad vectors recognizing CD46 for gene therapy.
Materials and methods
Cells
Human PBMCs (Cambrex Bio Science, Walkersville, MD, USA) were cultured in culture medium (Roswell Park Memorial Institute (RPMI)1640 supplemented with 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 4 mM L-glutamine, 10% fetal bovine serum (FBS)). HeLa cells (human cervix epitheloid carcinoma) were cultured with Dulbecco's modified Eagle's medium supplemented with 10% FBS. A549 cells (a human lung epithelial cell line) were cultured with F-12K medium supplemented with 10% FBS. K562 cells (human chronic myelogenous leukemia in blast crisis), U937 cells (a human lymphoma cell line), Molt-4 (a human T-cell leukemia cell line) and KG-1a cells (human bone marrow acute myelogenous leukemia) were cultured with RPMI1640 medium supplemented with 10% FBS. Human bone marrow-derived CD34 + cells (Cambrex Bio Science) were cultured with StemSpan 2000 containing cytokine cocktail StemSpan CC100 (human Flt-3 ligand (100 ng/ml), human stem cell factor (100 ng/ml), human IL-3 (20 ng/ml) and human IL-6 (20 ng/ml)) (StemCell Technologies Inc., Vancouver, BC, Canada).
Ad vectors
Ad35 vectors containing a cytomegalovirus promoterdriven enhanced GFP expression cassette or a cytomegalovirus promoter-driven firefly luciferase expression cassette, Ad35GFP and Ad35L, respectively, were constructed by the improved in vitro ligation method described previously. 40 GFP-expressing conventional Ad5-based vectors, Ad5GFP and fiber-substituted Ad5-based vectors displaying the fiber knob and shaft of Ad35, Ad5F35GFP, were also constructed as described previously.
25,41 Determination of the virus particle titers of Ad vectors was accomplished following the method described by Maizel et al. 42 Ad35GFP was UV-and heatinactivated by exposure to 254-nm radiation for 1 h, and by incubation at 481C for 1 h, respectively. The efficiency of the inactivation was confirmed by comparing the transduction efficiencies of control and inactivated Ad35GFP.
Downregulation of surface CD46 by infection with Ad35 vectors
For the present time course study of the downregulation of surface CD46, PBMCs were seeded in a 96-well plate at 5.0 Â 10 4 cells/well and incubated with Ad35GFP at 10 000 VP/cell. PBMCs were harvested at various time points and subjected to flow cytometric analyses as described below. For the study of the dose-dependent downregulation of surface CD46, PBMCs were infected with Ad35GFP at the indicated vector doses. After incubation for 24 h, the surface expression levels of CD46 were measured by flow cytometry. Analysis of the downregulation of surface CD46 levels in response to various types of Ad vectors was similarly performed. Ad35 vector-mediated decrease in the surface CD46 levels was also assessed in various types of human cells (Molt-4, KG-1a, K562, U937, A549, HeLa and human bone marrow-derived CD34 + cells). Cells were seeded in a 24-or 96-well plate and infected with Ad35L at 10 000 VP/cell. After incubation for 24 h, CD46 expression levels were assessed by flow cytometry.
Ad35 fiber knob-mediated downregulation of surface CD46
Recombinant Ad35 fiber knob protein was constructed similarly to Ad5 fiber knob, 43 using Ad35 vector plasmid pAdMS4 44 and the following primers: forward, 5 0 -tcg aat tca cct tat gga ctg gaa taa acc c-3 0 (EcoRI site is underlined); reverse, 5 0 -atg cgg ccg ctt agt tgt cgt ctt ctg taa tgt aag a-3 0 (NotI site is underlined). Ad5 fiber knob protein was prepared previously. 43 PBMCs, which were seeded in a 96-well plate at 5.0 Â 10 4 cells/well, were incubated with the Ad5 or Ad35 fiber knob at the indicated concentrations. Surface CD46 expression levels were examined 24 h after incubation by flow cytometry as described below.
Western blotting analysis for CD46 expression
PBMCs (5.0 Â 10 5 cells) were seeded in a 24-well plate and infected with Ad35GFP at 10 000 VP/cell. They were then collected at the indicated time points, washed and treated with lysis buffer (25 mM Tris, 1% Triton X-100, 0.5% sodium deoxycholate, 5 mM ethylenediaminetetraacetic acid, 150 mM NaCl) containing a cocktail of protease inhibitors (Sigma, St Louis, MO, USA). The protein content in the cell lysates was measured with an assay kit from Bio-Rad (Hercules, CA, USA), using bovine serum albumin (BSA) as a standard. Protein samples (10 mg) were subjected to nonreducing sodium dodecyl sulfate-12.5% polyacrylamide gel electrophoresis, and the separated proteins were transferred to a nitrocellulose membrane. After blocking nonspecific binding, CD46 was detected with anti-CD46 rabbit serum (1:5000; kindly provided by Dr Tsukasa Seya, Hokkaido University, Japan), followed by incubation in the presence of horseradish peroxidase-labeled goat antirabbit second antibody (1:6000, Cell Signaling, Danvers, MA, USA). Signals on the membrane were visualized and analyzed as described previously. 40 To verify equal loading, the blots were stripped and probed with a rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:3000, Trevigen, Gaithersburg, MD, USA) followed by treatment with an horseradish peroxidaseconjugated goat anti-rabbit second antibody (1:5000, Cell Signaling).
RT-PCR analysis for CD46 expression
PBMCs were infected with Ad35GFP as performed in Western blotting analysis. After infection, the cells were collected at the indicated time points and total RNA was isolated from the cells using Isogen reagent (Nippon Gene, Tokyo, Japan). First-strand cDNA templates were synthesized as previously described, 43 and the templates were subjected to PCR amplification using sets of primers for human CD46 45 and GAPDH. 46 The cycling parameters were 30 s at 941C, 30 s at 551C and 30 s at 721C for both CD46 and GAPDH. PCR products were separated by electrophoresis on a 2.0% agarose gel and visualized with ethidium bromide.
Recovery of CD46 expression from the Ad35 vectormediated downregulation of surface CD46 expression
PBMCs seeded in a six-well plate were infected with Ad35GFP at 10 000 VP/cell. After a 24-h incubation, the cells were collected and washed twice to remove the Ad35GFP. The PBMCs were then resuspended in fresh culture medium, and subsequently cultured at 371C PBMCs were harvested at the indicated time points and subjected to flow cytometric analysis to measure CD46 expression.
Flow cytometry
Cells were harvested, washed with FACS buffer (phosphate-buffered saline (PBS) containing 1% BSA and 0.01% sodium azide) and then fixed for 10 min with 3.2% paraformaldehyde-containing PBS. For the simultaneous analysis of expression levels of CD46 and CD19 (B-cell marker) or CD3 (T cell marker), PBMCs were incubated with both fluorescein isothiocyanate (FITC)-labeled anti-human CD46 antibody (E4.3, Pharmingen) and PE-conjugated anti-human CD19 antibody (HIB19, Pharmingen) or allophycocyanin (APC)-labeled anti-human CD3 antibody (UCHT1, eBioscience, San Diego, CA, USA). After incubation for 45 min on ice, stained cells were subjected to flow cytometry analysis as described above.
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